Preston Klassen

2010 - Orexigen Therapeutics

In 2010, Preston Klassen earned a total compensation of $1M as Head of Global Contrave Program and Senior Vice President, Product Development at Orexigen Therapeutics, a 14% decrease compared to previous year.

Compensation breakdown

Bonus$395,000
Option Awards$285,311
Salary$332,052
Other$120
Total$1,012,483

Klassen received $395K in bonus, accounting for 39% of the total pay in 2010.

Klassen also received $285.3K in option awards, $332.1K in salary and $120 in other compensation.

Rankings

In 2010, Preston Klassen's compensation ranked 5,265th out of 10,439 executives tracked by ExecPay. In other words, Klassen earned more than 49.6% of executives.

ClassificationRankingPercentile
All
5,265
out of 10,439
50th
Division
Manufacturing
1,899
out of 3,838
51st
Major group
Chemicals And Allied Products
393
out of 921
57th
Industry group
Drugs
232
out of 680
66th
Industry
Pharmaceutical Preparations
177
out of 481
63rd
Source: SEC filing on April 23, 2013.

Klassen's colleagues

We found five more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2010.

2010

Michael Narachi

Orexigen Therapeutics

Chief Executive Officer

2010

Heather Turner

Orexigen Therapeutics

General Counsel

2010

Mark Booth

Orexigen Therapeutics

Chief Commercial Officer

2010

Graham Cooper

Orexigen Therapeutics

Chief Financial Officer

2010

Joseph Hagan

Orexigen Therapeutics

Chief Business Officer

News

You may also like